Medical equipment industry
IRIS and Boehringer Mannheim, two leading companies in the medical diagnostics industry, have collaborated to develop the IRIS/BMC 900/UDx Urine Pathology System, a high-capacity urinalysis system designed for complete urinalytical profiles. The system integrates advanced technologies, including microscopy, automated intelligent microscopy, and absolute specific gravity measurement, offering unparalleled
Pharmaceutical industry
St. Jude Medical, Inc., the manufacturer of the world's most preferred mechanical heart valves, has entered into an alliance with The DuPont Merck Pharmaceutical Company to jointly develop educational programs on the use of anticoagulants with mechanical heart valves. This partnership aims to enhance the cardiovascular disease management
Pharmaceutical industry
Pharmacyclics, a private company developing biometallic pharmaceuticals, has announced a marketing and distribution agreement with E-Z-EM, a leading manufacturer and distributor of oral and gastrointestinal contrast agents. Under the agreement, E-Z-EM will gain the right to sell, market, and distribute GADOLITE, an oral contrast agent candidate for improving MRI imaging
Medical equipment industry
Biocircuits Corporation, a leading developer of diagnostic testing systems, has announced the receipt of two additional patents from the U.S. Trade and Patent office, further solidifying its position in the diagnostic testing market. The patents cover improvements to the company's lipid/polymer technology, which is used in
Medical equipment industry
Athena Neurosciences has secured an exclusive worldwide license from Duke University to use technology and patent rights related to the apolipoprotein E (ApoE) gene as a diagnostic test for Alzheimer's disease. This collaboration marks a significant step forward in the development of a test that can help diagnose
Medical equipment industry
Positron Corporation announced a significant increase in revenues, fueled by the shipment of two POSICAM(TM) systems, leading to a 490% revenue growth in the second quarter of 1995. The company's revenues rose to $2,986,000 from $506,000 in the same quarter of 1994, with gross
Medical equipment industry
Spectral Diagnostics Inc., developers of Point-of-Care cardiac diagnostics, reported a net loss of $9,030,000 in fiscal 1995, compared to a net loss of $3,368,787 in fiscal 1994. The company had total assets of $40,942,000, with $32,176,000 in cash and short-term securities, at
Medical equipment industry
BioWhittaker, Inc., a leading manufacturer of biotechnology and biopharmaceutical supply products, has taken a significant step towards refocusing its resources on its core business. The Company has executed a non-binding letter of intent with Wampole Laboratories, a division of Carter-Wallace, Inc., to sell its diagnostic test kit product line. This
Medical equipment industry
Quidel Corp., a leading developer and marketer of rapid diagnostic tests, announced a 61 percent increase in net product sales for the first quarter of fiscal year 1996, driven by growth in international sales and the successful integration of Pacific Biotech, a company acquired in the fourth quarter of fiscal
Medical equipment industry
Biologix President and Board of Directors have announced a strategic merger with Advanced Health Institute of Technology, a New York-based organization. This arrangement signals a significant shift in Biologix's direction and may lead to enhanced sales, earnings, and growth in shareholder value. The merged entity will gain access
Medical equipment industry
CompuCyte Corporation, a Cambridge, Mass.-based developer of advanced information technology products for medical laboratories, has received $2 million in equity financing from American Healthcare Systems, a $36 billion national healthcare alliance. This investment brings the total amount invested in CompuCyte to $8.6 million, with $2.3 million coming
Medical equipment industry
SpaceLabs Medical, Inc., a leading developer of patient monitoring products and clinical information systems, reported financial results for the second quarter ended July 1, 1995. The company's net income for the quarter was $4.6 million, including restructuring and reorganization charges of $337,000. Excluding these costs, earnings
